A comparison study of dual-energy spectral CT and 18F-FDG PET/CT in primary tumors and lymph nodes of lung cancer
PDF
Cite
Share
Request
Modality-Based (US, CT, MRI, PET-CT) Imaging - Original Article
P: 275-282
March 2021

A comparison study of dual-energy spectral CT and 18F-FDG PET/CT in primary tumors and lymph nodes of lung cancer

Diagn Interv Radiol 2021;27(2):275-282
1. Department of Nuclear Medicine Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey
2. Department of Radiology, Ankara University School of Medicine, Ibni Sina Hospital, Ankara, Turkey
3. Department of Radiation Oncology, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey
4. Department of Radiology, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey
5. Department of Biochemistry, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey
No information available.
No information available
Received Date: 03.02.2020
Accepted Date: 25.04.2020
PDF
Cite
Share
Request

ABSTRACT

PURPOSE

We aimed to investigate whether there is a correlation between dual-energy spectral computed tomography (DESCT) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) parameters in primary tumor and metastatic lymph nodes in patients with newly diagnosed lung cancer.

METHODS

Primary tumor and metastatic lymph nodes of 68 patients diagnosed with lung cancer were evaluated retrospectively with 18F-FDG PET/CT and DESCT imaging. The histologic subtypes were adenocarcinoma (n=29), squamous cell carcinoma (SCC) (n=26), small cell lung cancer (SCLC) (n=11), and large cell neuroendocrine cancer (LCNEC) (n=2). In terms of PET parameters, SUVmax, SUVmean, SULmax, SULmean, SULpeak, and normalized SUL values were obtained for primary tumors and metastatic lymph nodes. In terms of DESCT parameters, maximum and mean iodine content (IC), normalized IC values, iodine enhancement (IE) and normalized IE values were calculated.

RESULTS

We found no correlation between DESCT and 18F-FDG PET/CT parameters in primary tumors and metastatic lymph nodes. In addition, no correlation was found in the analysis performed in any of the histologic subgroups. In patients with a primary tumor <3 cm, there was a moderate negative correlation between the parameters SUVmax-ICmax (r= -0.456, p = 0.043), SUVmean-ICmax (r= -0.464, p = 0.039) SULmean-ICmax (r= -0.497, p = 0.026), SUVmax-ICmean (r= -0.527, p = 0.020), SULmean-ICmean (r= -0.499, p = 0.025), and SULpeak-ICmean (r= -0.488, p = 0.029).

CONCLUSION

We consider that DESCT and 18F-FDG PET/CT indicate different characteristics of the tumors and should not supersede each other.